Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-10 5:07 pm Purchase |
2022-01-31 | 13G | FibroGen, Inc. FGEN |
Point72 Asset Management, L.P. | 4,666,107 5.000% |
4,666,107 (New Position) |
Filing History |
| 2022-01-10 4:52 pm Purchase |
2022-01-07 | 13G | BellRing Brands, Inc. BRBR |
Point72 Asset Management, L.P. | 1,983,182 5.100% |
1,983,182 (New Position) |
Filing History |
| 2022-01-04 5:20 pm Purchase |
2022-01-03 | 13G | Applied Therapeutics, Inc. APLT |
Point72 Asset Management, L.P. | 2,556,976 9.800% |
2,556,976 (New Position) |
Filing History |
| 2021-12-21 5:13 pm Purchase |
2021-12-20 | 13G | Atara Biotherapeutics, Inc. ATRA |
Point72 Asset Management, L.P. | 182,721 5.200% |
182,721 (New Position) |
Filing History |
| 2021-12-15 5:14 pm Purchase |
2021-12-14 | 13G | Arcutis Biotherapeutics, Inc. ARQT |
Point72 Asset Management, L.P. | 2,550,736 5.100% |
2,550,736 (New Position) |
Filing History |
| 2021-12-13 4:58 pm Purchase |
2021-12-10 | 13G | Akero Therapeutics, Inc. AKRO |
Point72 Asset Management, L.P. | 1,751,563 5.000% |
1,751,563 (New Position) |
Filing History |
| 2021-12-06 5:22 pm Purchase |
2021-12-03 | 13G | Krystal Biotech, Inc. KRYS |
Point72 Asset Management, L.P. | 1,343,242 5.400% |
1,343,242 (New Position) |
Filing History |
| 2021-11-17 5:27 pm Purchase |
2021-11-09 | 13G | X4 Pharmaceuticals, Inc. XFOR |
Point72 Asset Management, L.P. | 1,500,243 5.600% |
1,500,243 (New Position) |
Filing History |
| 2021-10-28 5:24 pm Purchase |
2021-10-27 | 13G | Xenon Pharmaceuticals Inc. XENE |
Point72 Asset Management, L.P. | 2,641,253 5.100% |
2,641,253 (New Position) |
Filing History |
| 2021-10-28 5:05 pm Purchase |
2021-10-18 | 13G | Oyster Point Pharma, Inc. OYST |
Point72 Asset Management, L.P. | 2,297,761 8.800% |
2,297,761 (New Position) |
Filing History |
| 2021-10-14 5:12 pm Purchase |
2021-10-13 | 13G | Cidara Therapeutics, Inc. CDTX |
Point72 Asset Management, L.P. | 210,000 6.300% |
210,000 (New Position) |
Filing History |
| 2021-10-07 5:24 pm Purchase |
2021-10-06 | 13G | Praxis Precision Medicines, Inc. PRAX |
Point72 Asset Management, L.P. | 168,712 5.700% |
168,712 (New Position) |
Filing History |
| 2021-09-21 4:51 pm Purchase |
2021-09-17 | 13G | Avalo Therapeutics, Inc. AVTX |
Point72 Asset Management, L.P. | 2,087 5.400% |
2,087 (New Position) |
Filing History |
| 2021-09-21 4:34 pm Purchase |
2021-09-20 | 13G | Protagonist Therapeutics, Inc. PTGX |
Point72 Asset Management, L.P. | 4,329,030 9.100% |
4,329,030 (New Position) |
Filing History |
| 2021-09-13 4:56 pm Purchase |
2021-09-10 | 13G | Growth Capital Acquisition Corp. GCAC |
Point72 Asset Management, L.P. | 1,080,424 6.300% |
1,080,424 (New Position) |
Filing History |
| 2021-09-07 4:35 pm Purchase |
2021-08-25 | 13G | Theravance Biopharma, Inc. TBPH |
Point72 Asset Management, L.P. | 5,144,637 7.000% |
5,144,637 (New Position) |
Filing History |
| 2021-07-21 4:12 pm Purchase |
2021-07-20 | 13G | Poshmark, Inc. POSH |
Point72 Asset Management, L.P. | 883,847 5.700% |
883,847 (New Position) |
Filing History |
| 2021-07-14 5:19 pm Purchase |
2021-07-13 | 13G | Golar LNG Limited GLNG |
Point72 Asset Management, L.P. | 5,581,336 5.100% |
5,581,336 (New Position) |
Filing History |
| 2021-05-26 5:01 pm Purchase |
2021-05-17 | 13G | Aerpio Pharmaceuticals, Inc. ARPO |
Point72 Asset Management, L.P. | 121,667 3.900% |
121,667 (New Position) |
Filing History |
| 2021-05-18 4:32 pm Purchase |
2021-05-11 | 13G | F-star Therapeutics, Inc. FSTX |
Point72 Asset Management, L.P. | 1,100,000 5.700% |
1,100,000 (New Position) |
Filing History |